Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) CEO Scott M. Brinker acquired 2,873 shares of the firm's stock in a transaction that occurred on Monday, July 28th. The shares were purchased at an average cost of $17.40 per share, with a total value of $49,990.20. Following the completion of the acquisition, the chief executive officer owned 207,486 shares in the company, valued at $3,610,256.40. This trade represents a 1.40% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Healthpeak Properties Trading Down 0.7%
Shares of NYSE:DOC traded down $0.13 during trading on Friday, hitting $16.82. 2,010,175 shares of the company's stock were exchanged, compared to its average volume of 5,920,715. Healthpeak Properties, Inc. has a 1-year low of $16.64 and a 1-year high of $23.26. The firm has a 50-day moving average price of $17.69 and a two-hundred day moving average price of $18.77. The company has a current ratio of 1.28, a quick ratio of 1.35 and a debt-to-equity ratio of 1.06. The firm has a market cap of $11.69 billion, a P/E ratio of 70.03, a PEG ratio of 2.20 and a beta of 1.03.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The company had revenue of $694.35 million during the quarter, compared to analysts' expectations of $697.14 million. During the same quarter in the previous year, the company earned $0.45 EPS. Healthpeak Properties's revenue was down .2% on a year-over-year basis. Equities analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Announces Dividend
The company also recently disclosed a monthly dividend, which will be paid on Tuesday, September 30th. Investors of record on Friday, September 19th will be paid a dividend of $0.1017 per share. The ex-dividend date of this dividend is Friday, September 19th. This represents a c) annualized dividend and a yield of 7.3%. Healthpeak Properties's dividend payout ratio (DPR) is presently 508.33%.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of the company. NEOS Investment Management LLC lifted its stake in Healthpeak Properties by 31.0% in the fourth quarter. NEOS Investment Management LLC now owns 31,572 shares of the real estate investment trust's stock valued at $640,000 after buying an additional 7,464 shares in the last quarter. Blair William & Co. IL lifted its stake in Healthpeak Properties by 61.3% in the fourth quarter. Blair William & Co. IL now owns 17,916 shares of the real estate investment trust's stock valued at $363,000 after buying an additional 6,810 shares in the last quarter. Norges Bank bought a new position in Healthpeak Properties in the fourth quarter valued at approximately $166,804,000. Pictet Asset Management Holding SA lifted its stake in Healthpeak Properties by 5.8% in the fourth quarter. Pictet Asset Management Holding SA now owns 1,051,330 shares of the real estate investment trust's stock valued at $21,310,000 after buying an additional 57,432 shares in the last quarter. Finally, DnB Asset Management AS lifted its stake in Healthpeak Properties by 3.0% in the fourth quarter. DnB Asset Management AS now owns 145,884 shares of the real estate investment trust's stock valued at $2,957,000 after buying an additional 4,298 shares in the last quarter. Institutional investors own 93.57% of the company's stock.
Analysts Set New Price Targets
A number of analysts have weighed in on DOC shares. Robert W. Baird set a $21.00 price target on shares of Healthpeak Properties and gave the company an "outperform" rating in a report on Wednesday. Evercore ISI reduced their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Wedbush reduced their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Argus reissued a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a report on Tuesday, April 29th. Finally, Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of "Moderate Buy" and an average price target of $23.00.
View Our Latest Stock Report on DOC
Healthpeak Properties Company Profile
(
Get Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.